Delivery Order SPE2DB20D2104-SPE2DB24FR47M
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,225.44 Firm Fixed Price delivery order contract is for the supply of NovologTM 100 unit/mL FlexPenTM 3mL, a medication used for diabetes management. The contract has an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of pharmaceutical products. The $7,217.13 firm fixed-price contract covers the delivery of Novolog 100 Unit/mL Flexpen 3mL, a diabetes medication, with a completion date of July 28, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the delivery of NovologTM 100 Unit/mL FlexPenTM 3mL, a common insulin delivery device. The $2,097.12 delivery order contract is a firm fixed-price arrangement with an ultimate completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NovologTM 100 unit/mL FlexPen 3mL, a prescription insulin medication. The fixed-price, firm-fixed-price contract has a ceiling value of $1,327.70 and an ultimate completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL, a medical product used for diabetes management. The contract has a ceiling value of $1,548.00 and runs through November 30, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,733.85 firm-fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product, to support the U.S. government's healthcare needs. The contract has an ultimate completion date of December 7, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,527.05 firm fixed-price contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of medication. The contract has an ultimate completion date of February 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a ceiling value of $2,197.01 and is a firm fixed price delivery order type, with an ultimate completion date of June 11, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,661.91 firm fixed price contract is for the supply of Novolog 100 Unit/mL Flexpen 3mL, a prescription medication used for the treatment of diabetes. The contract has an ultimate completion date of January 23, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 28, 2026, by the Defense Logistics Agency for NovoLog 100 Unit/mL FlexPen 3mL insulin pens valued at $7,350.48. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of January 29, 2026. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order falls under Amerisourcebergen's larger Indefinite Delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR47MDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of NovologĀ® 100 unit/mL FlexPen 3mL. The $2,445.30 firm-fixed-price contract has a completion date of December 6, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and various other medical commodities. This delivery order is part of that larger IDC vehicle, which supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract was awarded through full and open competition without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/5/23 |